BIOMAT Database Logo BIOMAT Database Logo

FPL 52758 and disodium cromoglycate (INTAL) in exercise-induced infantile bronchoconstriction. 1982

K P Ringel, and A R el Nur, and F Karg

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002867 Chromones 1,4-Benzopyrones,Chromone,1,4 Benzopyrones
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004205 Cromolyn Sodium A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Disodium Cromoglycate,Sodium Cromoglycate,Aarane,Bicromat Spray,Cromoglicic Acid,Cromoglycate,Cromoglycic Acid,Cromolyn,FPL-670,Intal,Lomudal,Nalcrom,Nasalcrom,Opticrom,Vicrom,Acid, Cromoglicic,Acid, Cromoglycic,Cromoglycate, Disodium,Cromoglycate, Sodium,FPL 670,FPL670
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

K P Ringel, and A R el Nur, and F Karg
Treatment of asthma with disodium cromoglycate (FPL 670, 'Intal').
January 1969, Respiration; international review of thoracic diseases,
K P Ringel, and A R el Nur, and F Karg
Disodium cromoglycate (INTAL).
January 1972, The Medical journal of Australia,
K P Ringel, and A R el Nur, and F Karg
Disodium cromoglycate (Intal).
October 1971, The Medical journal of Australia,
K P Ringel, and A R el Nur, and F Karg
Disodium cromoglycate (INTAL).
December 1971, The Medical journal of Australia,
K P Ringel, and A R el Nur, and F Karg
Disodium cromoglycate (INTAL).
November 1971, The Medical journal of Australia,
K P Ringel, and A R el Nur, and F Karg
Disodium cromoglycate (Intal).
January 1970, Advances in drug research,
K P Ringel, and A R el Nur, and F Karg
Bronchodilator effects of disodium cromoglycate in exercise-induced bronchoconstriction.
October 1983, British journal of diseases of the chest,
K P Ringel, and A R el Nur, and F Karg
Intranasal Intal (disodium cromoglycate).
October 1971, The Medical journal of Australia,
K P Ringel, and A R el Nur, and F Karg
Intranasal intal (disodium cromoglycate).
September 1971, The Medical journal of Australia,
K P Ringel, and A R el Nur, and F Karg
Protection against exercise-induced bronchoconstriction by nebulized disodium cromoglycate.
February 1989, The American review of respiratory disease,
Copied contents to your clipboard!